MedPath

Naproxen

Naproxen Tablets, USP

Approved
Approval ID

942c2438-9fe9-4f31-9617-3c6d029154d3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 6, 2010

Manufacturers
FDA

Blenheim Pharmacal, Inc.

DUNS: 171434587

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naproxen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10544-016
Application NumberANDA075927
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naproxen
Product Specifications
Route of AdministrationORAL
Effective DateOctober 6, 2010
FDA Product Classification

INGREDIENTS (4)

NAPROXENActive
Quantity: 500 mg in 1 1
Code: 57Y76R9ATQ
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naproxen - FDA Drug Approval Details